TEVA PHARMACEUTICALS INTERNATIONAL GMBH;SMITH Mark Alan;CLAASSEN-PUNT Carine;CHEN Ling;GERSHON Ari Andrew
发明人:
SMITH Mark Alan,CLAASSEN-PUNT Carine,CHEN Ling,GERSHON Ari Andrew
申请号：
IL26940319
公开号：
IL269403D0
申请日:
2019.09.16
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
The disclosure is directed to methods of treating schizophrenia or bipolar disorder by subcutaneously administering a sustained-release dosage form of olanzapine, or a pharmaceutically acceptable salt thereof. Methods of subcutaneously administering olanzapine, or a pharmaceutically acceptable salt thereof, are also described.
